Contact

Inflammation
Markers

Inflammation is a common pathological process in clinical practice and may occur in tissues and organs throughout the body. It is associated with conditions such as bacterial and viral infections, autoimmune diseases, tissue injury, and chronic inflammatory disorders. Inflammatory responses may present with symptoms including fever, pain, swelling, redness, and impaired organ function, often accompanied by systemic changes such as elevated inflammatory biomarker levels. By measuring inflammation marker concentrations, KSB inflammation assays support the evaluation of inflammatory status and assist in the clinical assessment, screening, monitoring, and management of inflammation-related conditions.

KSB Inflammation Markers

VeriGoldTM
Gold-Conjugated Immunoassay

VeriLumenTM Fluorescence Immunoassay

Inflammation markers are biologically significant substances associated with the body’s immune and inflammatory responses to infection, tissue damage, autoimmune activity, and other pathological conditions. These biomarkers are released or elevated during inflammatory processes and may reflect the presence, severity, and progression of acute or chronic inflammation throughout different tissues and organ systems. Changes in inflammation marker concentrations can provide clinically relevant information regarding immune activation, disease progression, therapeutic response, and overall inflammatory status.

The measurement of inflammation markers is widely applied in clinical diagnostics to support the evaluation of bacterial and viral infections, autoimmune diseases, cardiovascular disorders, tissue injury, sepsis, and chronic inflammatory conditions. Variations in inflammatory biomarker concentrations may provide clinically relevant information regarding disease severity, immune response, therapeutic effectiveness, and overall inflammatory status. As a result, inflammation testing plays an important role in clinical assessment, disease screening, treatment monitoring, prognosis evaluation, and patient management across a broad range of medical specialties.

Inflammation markers can be detected in various biological samples, including whole blood, serum, plasma, and other body fluids, depending on the specific analyte and intended clinical application. Their detection is commonly achieved through immunological and analytical laboratory methods designed to provide accurate and reproducible results. Among these techniques, immunoassay-based technologies are particularly important due to their sensitivity, specificity, rapid performance, and compatibility with modern clinical and point-of-care diagnostic workflows.

In particular, immunochromatographic lateral flow assays provide a rapid and convenient platform for inflammation marker detection in laboratory and point-of-care settings. KSB assays enable the quantitative analysis of inflammation markers within a short testing time, supporting timely clinical evaluation and decision-making. By combining antibody-based recognition with membrane-driven capillary flow technology, our lateral flow assays offer efficient, user-friendly, and cost-effective solutions for inflammation testing, contributing to improved accessibility and broader application of inflammatory diagnostics in modern healthcare.

Explore
Your
Options

Shenzhen Kang Sheng Bao
Biotechnology Co., Ltd.

Second Floor, Block 3, Anda

Electronic Industrial Park,

Fuhai, Bao’an District,

518103 Shenzhen, 

Guangdong Province, PRC

 

+86 0755 27417763 

 

info@ksbbiotech.com